ERBB3 and neoplasm: In breast cancer, miR-125a and miR-125b were reported down-regulated in biopsy specimens and as tumor suppressors [23,29,30] by mediating the ERBB2 and ERBB3 pathway [22] or by targeting the ETS1 gene [31].